Physician profile
Selwin Abraham
NPI 1649425430
$7,805.99
in general payments reported to CMS, 2019-2025
43 companies · $812 in 2025
The $812 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $860 · 2020: $737 · 2021: $648 · 2022: $1,725 · 2023: $1,659 · 2024: $1,364 · 2025: $812.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,835.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,835.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,521.38 | 2021-2025 | Onyx Frontier, Ffrangio, Linq II |
| Novartis Pharmaceuticals Corporation | $784.58 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $613.21 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $609.39 | 2020-2025 | Watchman Flx, Watchman Access System, Wolverine Coronary Cutting Balloon |
| Cardiovascular Systems INC. | $564.35 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $423.95 | 2020-2024 | Wainua, Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $298.94 | 2019-2025 | Lifevest |
| Abiomed | $284.56 | 2020-2024 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $205.95 | 2019-2025 | Jardiance |
| Alnylam Pharmaceuticals INC. | $196.48 | 2022-2025 | Amvuttra |
| Amgen INC. | $194.88 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $189.95 | 2022-2023 | Verquvo |
| Shockwave Medical, INC | $170.60 | 2021-2024 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Pfizer INC. | $168.03 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $145.89 | 2020-2025 | Camzyos |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $134.86 | 2024-2025 | Uptravi, Opsumit |
| Abbott Laboratories | $129.99 | 2023-2024 | Optis, Aptivue, Perclose Prostyle |
| Penumbra, INC. | $119.75 | 2021 | |
| Angiodynamics, INC. | $118.21 | 2019-2024 | Alphavac |
| Kestra Medical Technology Services, INC. | $106.56 | 2025 | Assure Wcd |
| Edwards Lifesciences Corporation | $99.51 | 2024 | Sapien 3 Ultra Resilia |
| Lantheus Medical Imaging, INC. | $72.84 | 2024-2025 | |
| Baxter Healthcare | $63.58 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Kiniksa Pharmaceuticals International, Plc | $57.72 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $54.07 | 2023-2025 | |
| Daiichi Sankyo INC. | $49.52 | 2022-2023 | Injectafer |
| Medtronic Vascular, INC. | $41.14 | 2020 | |
| Vital Connect, INC | $39.69 | 2024-2025 | Vitalpatch Rtm |
| Bayer Healthcare Pharmaceuticals INC. | $34.90 | 2025 | |
| Novo Nordisk INC | $34.13 | 2023-2024 | Ozempic, Rybelsus |
| Teleflex LLC | $32.59 | 2023 | Vascband |
| Cvrx, INC. | $31.34 | 2025 | Barostim Neo System |
| Heartflow, INC. | $30.61 | 2025 | |
| Esperion Therapeutics, INC. | $28.98 | 2020-2022 | |
| Kiniksa Pharmaceuticals, Ltd. | $21.86 | 2023 | Arcalyst |
| Bridgebio Pharma, INC. | $20.61 | 2025 | Attruby |
| Inari Medical, INC. | $20.00 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Siemens Medical Solutions USA, INC. | $19.00 | 2024 | Artis Icono Floor |
| Philips North America LLC | $16.45 | 2023 | |
| Glaxosmithkline, LLC. | $16.42 | 2024 | Arexvy, Trelegy Ellipta |
| Amarin Pharma, INC. | $15.35 | 2021 | |
| Sanofi-Aventis U.S. LLC | $13.08 | 2019 | |
| Biotronik INC. | $11.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Selwin Abraham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.